The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma.
 
Amarendra Kumar Neppalli
No Relationships to Disclose
 
Judith Shizuru
No Relationships to Disclose
 
Laura J. Johnston
Consulting or Advisory Role - Seagen
 
Lori S. Muffly
No Relationships to Disclose
 
Wen-Kai Weng
No Relationships to Disclose
 
Robert Negrin
Stock and Other Ownership Interests - Cell Source; Concentrx
Consulting or Advisory Role - Amgen; Cell Source; Jazz Pharmaceuticals; Sanofi; UpToDate
 
Everett Meyer
Stock and Other Ownership Interests - GigaGen
 
Ginna Laport
Employment - Corvus Pharmaceuticals
 
Robert Lowsky
No Relationships to Disclose
 
Sally Arai
No Relationships to Disclose
 
David Bernard Miklos
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pharmacyclics; Seagen
Speakers' Bureau - Sanofi
Research Funding - Adaptive Biotechnologies; Genentech; Janssen; Kite, a Gilead company; Novartis; Pharmacyclics; Roche
 
Andrew R. Rezvani
Research Funding - Pharmacyclics; Seagen